Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38

2004-08-01

Journal of Clinical Pharmacology , Volume 44 - Issue 8 p. 854- 860

Additional Metadata
Keywords	Genetic variants, Irinotecan, Pharmacokinetics, SN-38, UGT1A1, UGT1A9
Persistent URL	dx.doi.org/10.1177/0091270004267159, hdl.handle.net/1765/62227
Journal	Journal of Clinical Pharmacology
Organisation	Department of Medical Oncology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Paoluzzi, L, Singh, A.S, Price, D.K, Danesi, R, Mathijssen, A.H.J, Verweij, J, … Sparreboom, A. (2004). Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38. Journal of Clinical Pharmacology, 44(8), 854–860. doi:10.1177/0091270004267159

Publication